Xiaorong Zhou

3.0k total citations
120 papers, 2.2k citations indexed

About

Xiaorong Zhou is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaorong Zhou has authored 120 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 32 papers in Immunology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaorong Zhou's work include Immune Cell Function and Interaction (13 papers), RNA modifications and cancer (12 papers) and Ferroptosis and cancer prognosis (12 papers). Xiaorong Zhou is often cited by papers focused on Immune Cell Function and Interaction (13 papers), RNA modifications and cancer (12 papers) and Ferroptosis and cancer prognosis (12 papers). Xiaorong Zhou collaborates with scholars based in China, United States and United Kingdom. Xiaorong Zhou's co-authors include Eric J. Topol, Marc S. Penn, Bao‐Ping Pang, Zhongmin Zhou, Stanley L. Hazen, Farhad Forudi, A. Michael Lincoff, Xiaoling Ding, Kathryn A. O’Donnell and Annitta Morehead and has published in prestigious journals such as Nucleic Acids Research, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Xiaorong Zhou

110 papers receiving 2.2k citations

Peers

Countries citing papers authored by Xiaorong Zhou

Since Specialization

Citations

This map shows the geographic impact of Xiaorong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Zhou more than expected).

Fields of papers citing papers by Xiaorong Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaorong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Zhou. The network helps show where Xiaorong Zhou may publish in the future.

Co-authorship network of co-authors of Xiaorong Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorong Zhou. A scholar is included among the top collaborators of Xiaorong Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorong Zhou. Xiaorong Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Constructing a Pan-Cancer Prognostic Model via Machine Learning Based on Immunogenic Cell Death Genes and Identifying NT5E as a Biomarker in Head and Neck Cancer 2025 ·Current Issues in Molecular Biology ·(unknown), (unknown), Atsushi Kitani, Xiaorong Zhou, Liming Mao, Mengmeng Sang	0
2	Methyl Canthin-6-one-2-carboxylate Inhibits the Activation of the NLRP3 Inflammasome in Synovial Macrophages by Upregulating Nrf2 Expression 2025 ·Current Issues in Molecular Biology ·(unknown), (unknown), (unknown), Xiaorong Zhou, Yong Ling, Liming Mao, Zhifeng Gu	1
3	Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy 2025 ·Cancer Immunology Immunotherapy ·(unknown), Chong Wang, Yangchao Chen, Xiaorong Zhou, (unknown), Haijian Zhang	2
4	The intricate dance of tumor evolution: Exploring immune escape, tumor migration, drug resistance, and treatment strategies 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), (unknown), (unknown), Xiao Zhu, Xiaorong Zhou	2
5	The Relationship Between Benefit Finding and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease: The Mediating Effects of Self-Management 2024 ·International Journal of COPD ·(unknown), (unknown), Xiaorong Zhou, Yumei Li, Ke Chen, Tingting Kang, Wenting Du, (unknown)	3
6	Nanomolecular machines: Pioneering precision medicine for neoplastic diseases through advanced diagnosis and treatment 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), (unknown), Xiao Zhu, Tao Tao, Xiaorong Zhou	3
7	MiR-483-3p promotes dental pulp stem cells osteogenic differentiation via the MAPK signaling pathway by targeting ARRB2 2024 ·In Vitro Cellular & Developmental Biology - Animal ·Xin Yu, Juan Ge, Huimin Xie, (unknown), (unknown), Qinghua Wang, Xiaorong Zhou, Yan Zhou	2
8	Predicting Prognosis and Immunotherapy Response in Multiple Cancers Based on the Association of PANoptosis-Related Genes with Tumor Heterogeneity 2023 ·Genes ·Yunhan Wang, Boyu Zhang, (unknown), Jia Ge, (unknown), Jiawei Mao, Xiaorong Zhou, Liming Mao, Qiuyun Xu, Mengmeng Sang	5
9	High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity 2023 ·Genes ·Yunhan Wang, (unknown), (unknown), Jie Zhang, Qiuyun Xu, Xiaorong Zhou, Liming Mao	6
10	ADRB2 Regulates the Proliferation and Metastasis of Gastrointestinal Stromal Tumor Cells by Enhancing the ETV1-c-KIT Signaling 2023 ·Journal of Oncology ·(unknown), (unknown), (unknown), (unknown), Xiaorong Zhou, Xiaofei Zhi	1
11	Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators 2023 ·Molecules ·(unknown), Anqi Wang, Yunhan Wang, (unknown), Xiaorong Zhou, Qiuyun Xu, Liming Mao, (unknown)	6
12	Methyl Canthin-6-one-2-carboxylate Restrains the Migration/Invasion Properties of Fibroblast-like Synoviocytes by Suppressing the Hippo/YAP Signaling Pathway 2023 ·Pharmaceuticals ·(unknown), Yunhan Wang, Qiuyun Xu, Xiaorong Zhou, Yong Ling, Jie Zhang, Liming Mao	9
13	Higher frequency of circulating Vδ1 γδT cells in patients with advanced schistosomiasis 2021 ·Parasite Immunology ·(unknown), Lixia Wang, Yuan Hu, Jiabao Yi, Lun Wan, Yujuan Shen, Si Liu, Xiaorong Zhou, Jianping Cao	3
14	The role of the inflammasomes in the pathogenesis of uveitis 2021 ·Experimental Eye Research ·Qiuyun Xu, Jie Zhang, Tingyu Qin, (unknown), Hongtao Dong, Xiaorong Zhou, Shengping Hou, Liming Mao	17
15	Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease 2021 ·Molecules ·Qiuyun Xu, Xiaorong Zhou, Warren Strober, Liming Mao	19
16	Monocarboxylate Transporter 4 Triggered Cell Pyroptosis to Aggravate Intestinal Inflammation in Inflammatory Bowel Disease 2021 ·Frontiers in Immunology ·Yaodong Wang, Xiaorong Zhou, (unknown), Kejian Zou, Guanhua Chen, Ling Huang, (unknown), (unknown), Hongwei Xu, Zhaohui Xu, Huan Chen, Jiayu Chen, Sitang Gong, Xuan Zhou, Wanfu Xu, Junhong Zhao	22
17	SYL3C aptamer-anchored microemulsion co-loading β-elemene and PTX enhances the treatment of colorectal cancer 2019 ·Drug Delivery ·Xiaorong Zhou, (unknown), Nan Li, (unknown)	20
18	Gastric juice piR‐1245: A promising prognostic biomarker for gastric cancer 2019 ·Journal of Clinical Laboratory Analysis ·Xiaorong Zhou, Jianhong Liu, Aifeng Meng, Lihong Zhang, Min Wang, (unknown), Wei Peng, (unknown)	35
19	Modulation of Mutant KrasG12D -Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function 2018 ·Molecular Cancer Research ·Xiaorong Zhou, Mahesh S. Padanad, Bret M. Evers, Bethany Smith, (unknown), Shruthy Suresh, James A. Richardson, (unknown), Jingfei Zhu, Robert E. Hammer, Kathryn A. O’Donnell	23
20	PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis 2016 ·Cancer Research ·Xiaorong Zhou, Barrett L. Updegraff, Yabin Guo, Michael Peyton, Luc Girard, Jill E. Larsen, Xian‐Jin Xie, (unknown), Tae Hyun Hwang, Yang Xie, Jaime Rodriguez‐Canales, Pamela Villalobos, Carmen Behrens, Ignacio I. Wistuba, John D. Minna, Kathryn A. O’Donnell	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact